Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System

MISSISSAUGA, Ontario, Sept. 22, 2026 (GLOBE NEWSWIRE) — Traferox Technologies, Inc. today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the X°Port® Heart Preservation System, a device that enables static 10°C heart preservation during transport prior to transplantation. “The FDA clearance of X°Port Heart marks an important milestone for […]